View in EDS HTML Full Text PDF Full Text

Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.

Saved in:
Bibliographic Details
Title: Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.
Authors: Xia, Zhongjun1 (AUTHOR), Leng, Yun2 (AUTHOR), Fang, Baijun3 (AUTHOR), Liang, Yang1 (AUTHOR), Li, Wei4 (AUTHOR), Fu, Chengcheng5 (AUTHOR), Yang, Linhua6 (AUTHOR), Ke, Xiaoyan7 (AUTHOR), Jiang, Hua8 (AUTHOR), Weng, Jianyu9 (AUTHOR), Liu, Li10 (AUTHOR), Zhao, Yaozhong11 (AUTHOR), Zhang, Xuejun12 (AUTHOR), Huang, Zhongxia2 (AUTHOR), Liu, Aichun13 (AUTHOR), Shi, Qingzhi14 (AUTHOR), Gao, Yuhuan15 (AUTHOR), Chen, Xiequn16 (AUTHOR), Pan, Ling17 (AUTHOR), Cai, Zhen18 (AUTHOR)
Source: BMC Cancer. 10/14/2023, Vol. 23 Issue 1, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 172972066
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Xia%2C+Zhongjun%22">Xia, Zhongjun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Leng%2C+Yun%22">Leng, Yun</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fang%2C+Baijun%22">Fang, Baijun</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liang%2C+Yang%22">Liang, Yang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Wei%22">Li, Wei</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fu%2C+Chengcheng%22">Fu, Chengcheng</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Linhua%22">Yang, Linhua</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ke%2C+Xiaoyan%22">Ke, Xiaoyan</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jiang%2C+Hua%22">Jiang, Hua</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Weng%2C+Jianyu%22">Weng, Jianyu</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Li%22">Liu, Li</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhao%2C+Yaozhong%22">Zhao, Yaozhong</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Xuejun%22">Zhang, Xuejun</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Zhongxia%22">Huang, Zhongxia</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Aichun%22">Liu, Aichun</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shi%2C+Qingzhi%22">Shi, Qingzhi</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gao%2C+Yuhuan%22">Gao, Yuhuan</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Xiequn%22">Chen, Xiequn</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pan%2C+Ling%22">Pan, Ling</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cai%2C+Zhen%22">Cai, Zhen</searchLink><relatesTo>18</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22BMC+Cancer%22">BMC Cancer</searchLink>. 10/14/2023, Vol. 23 Issue 1, p1-14. 14p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=172972066
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12885-023-11489-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 14
        StartPage: 1
    Titles:
      – TitleFull: Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Xia, Zhongjun
      – PersonEntity:
          Name:
            NameFull: Leng, Yun
      – PersonEntity:
          Name:
            NameFull: Fang, Baijun
      – PersonEntity:
          Name:
            NameFull: Liang, Yang
      – PersonEntity:
          Name:
            NameFull: Li, Wei
      – PersonEntity:
          Name:
            NameFull: Fu, Chengcheng
      – PersonEntity:
          Name:
            NameFull: Yang, Linhua
      – PersonEntity:
          Name:
            NameFull: Ke, Xiaoyan
      – PersonEntity:
          Name:
            NameFull: Jiang, Hua
      – PersonEntity:
          Name:
            NameFull: Weng, Jianyu
      – PersonEntity:
          Name:
            NameFull: Liu, Li
      – PersonEntity:
          Name:
            NameFull: Zhao, Yaozhong
      – PersonEntity:
          Name:
            NameFull: Zhang, Xuejun
      – PersonEntity:
          Name:
            NameFull: Huang, Zhongxia
      – PersonEntity:
          Name:
            NameFull: Liu, Aichun
      – PersonEntity:
          Name:
            NameFull: Shi, Qingzhi
      – PersonEntity:
          Name:
            NameFull: Gao, Yuhuan
      – PersonEntity:
          Name:
            NameFull: Chen, Xiequn
      – PersonEntity:
          Name:
            NameFull: Pan, Ling
      – PersonEntity:
          Name:
            NameFull: Cai, Zhen
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 10
              Text: 10/14/2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 14712407
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC Cancer
              Type: main
ResultId 1